GR3031801T3 - Vitaletheine and use in cell culture and therapy. - Google Patents

Vitaletheine and use in cell culture and therapy.

Info

Publication number
GR3031801T3
GR3031801T3 GR990402894T GR990402894T GR3031801T3 GR 3031801 T3 GR3031801 T3 GR 3031801T3 GR 990402894 T GR990402894 T GR 990402894T GR 990402894 T GR990402894 T GR 990402894T GR 3031801 T3 GR3031801 T3 GR 3031801T3
Authority
GR
Greece
Prior art keywords
vitaletheine
therapy
cell culture
cell
derivatives
Prior art date
Application number
GR990402894T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3031801T3 publication Critical patent/GR3031801T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR990402894T 1990-07-06 1999-11-10 Vitaletheine and use in cell culture and therapy. GR3031801T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54910590A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
PCT/US1991/004726 WO1992000955A1 (en) 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy

Publications (1)

Publication Number Publication Date
GR3031801T3 true GR3031801T3 (en) 2000-02-29

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402894T GR3031801T3 (en) 1990-07-06 1999-11-10 Vitaletheine and use in cell culture and therapy.

Country Status (9)

Country Link
EP (1) EP0539525B1 (enExample)
JP (1) JP3259960B2 (enExample)
AT (1) ATE186048T1 (enExample)
AU (1) AU655598B2 (enExample)
DE (1) DE69131752T2 (enExample)
DK (1) DK0539525T3 (enExample)
ES (1) ES2139580T3 (enExample)
GR (1) GR3031801T3 (enExample)
WO (1) WO1992000955A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018877A4 (en) * 1995-10-17 2000-08-09 Dovetail Technologies Inc LOW MOLECULAR WEIGHT STIMULANTS OF BONE MARROW AND IMMUNE SYSTEM CELLS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
EP0538330B1 (en) * 1990-07-06 1995-10-11 University Of New Mexico Beta-alethine use in cell culture and therapy

Also Published As

Publication number Publication date
EP0539525A4 (enExample) 1994-01-12
JP3259960B2 (ja) 2002-02-25
EP0539525B1 (en) 1999-10-27
ES2139580T3 (es) 2000-02-16
DE69131752T2 (de) 2000-06-29
AU655598B2 (en) 1995-01-05
WO1992000955A1 (en) 1992-01-23
AU8500891A (en) 1992-02-04
DK0539525T3 (da) 2000-04-10
ATE186048T1 (de) 1999-11-15
DE69131752D1 (de) 1999-12-02
JPH06500106A (ja) 1994-01-06
EP0539525A1 (en) 1993-05-05
HK1014367A1 (en) 1999-09-24

Similar Documents

Publication Publication Date Title
DE60009956D1 (de) Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
BR9910251A (pt) Estimulação hematopoiética
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
ES8705845A1 (es) Procedimiento de preparar derivados benzonaftalenicos de utilidad terapeutica y cosmetica
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
ES8605375A1 (es) Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.
CA2213322A1 (en) Thiols to promote hematopoietic progenitor cell growth
ATE236638T1 (de) Neue verwendung von prostaglandinen
PT862452E (pt) Formulacao de estabilizacao para o ngf
ZA917767B (en) A nutritional composition and a process for its production
EP0380692A4 (en) Plant tissue culture process
IL72214A0 (en) Anthracycline derivatives,a microbiological process for their preparation and their use as cytostatics
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
GR3031801T3 (en) Vitaletheine and use in cell culture and therapy.
GR3018632T3 (en) Beta-alethine use in cell culture and therapy.
ATE124262T1 (de) Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.
EP0971725A4 (en) METHOD FOR TREATING SCAR TISSUE
ATE125571T1 (de) Interleukin-1-inhibitor.
EP0248217A3 (en) Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
DE2966082D1 (en) Process for growing human epidermal cells in tissue culture
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy